Home/Gland Pharma/Srinivas Sadu
SS

Srinivas Sadu

Managing Director & CEO

Gland Pharma

Gland Pharma Pipeline

DrugIndicationPhase
Enoxaparin Sodium InjectionAnticoagulationANDA Filed
Bivalirudin RTUAnticoagulation (PCI)Launched
Generic Biologics PipelineOncology, ImmunologyDevelopment
CDMO - Client Molecule AOncologyPhase III
Proprietary Novel Delivery SystemUndisclosedResearch